Trial Profile
Randomized, double-blind, Phase 1, dose-escalation study of Felbinac Trometamol in healthy Chinese volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Nov 2016
Price :
$35
*
At a glance
- Drugs Felbinac (Primary)
- Indications Inflammation; Pain
- Focus Adverse reactions; Pharmacodynamics
- 15 Nov 2016 New trial record